Drug intelligence / Profile preview

Compound Acanthopanax

Development stage: Unknown
Modality: Small Molecules
Administration: Oral

Overview

Compound Acanthopanax is a traditional Chinese medicine preparation, primarily composed of extracts from the root and rhizome of *Acanthopanax senticosus* (commonly known as Siberian ginseng or Eleuthero), often combined with other herbal ingredients in some formulations. It is used for its adaptogenic, anti-fatigue, and tonic effects. The main pharmacological actions include enhancing physical endurance, reducing fatigue, improving immune function, and providing antioxidant benefits. It may also have neuroprotective and sedative effects[2][1]. The exact mechanism of action is not fully elucidated but may involve modulation of central nervous system activity and enhancement of stress resistance[2].

Other names: 复方刺五加颗粒Compound Acanthopanax Granules

Beyond the preview

Go deeper on Compound Acanthopanax.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Compound Acanthopanax.

Explore the full profile